1 Recombinant Erythropoietin Drugs Market Overview
1.1 Recombinant Erythropoietin Drugs Product Scope
1.2 Recombinant Erythropoietin Drugs Segment by Type
1.2.1 Global Recombinant Erythropoietin Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 rhEPO
1.2.3 Erythropoiesis-Stimulating Agents (ESA)
1.3 Recombinant Erythropoietin Drugs Segment by Application
1.3.1 Global Recombinant Erythropoietin Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chronic Kidney Disease
1.3.3 Cancer Related Anemia
1.3.4 Others
1.4 Recombinant Erythropoietin Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Recombinant Erythropoietin Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Recombinant Erythropoietin Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Recombinant Erythropoietin Drugs Price Trends (2016-2027)
2 Recombinant Erythropoietin Drugs Estimates and Forecasts by Region
2.1 Global Recombinant Erythropoietin Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Recombinant Erythropoietin Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Recombinant Erythropoietin Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
2.4.3 China Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
2.4.6 India Recombinant Erythropoietin Drugs Estimates and Projections (2016-2027)
3 Global Recombinant Erythropoietin Drugs Competition Landscape by Players
3.1 Global Top Recombinant Erythropoietin Drugs Players by Sales (2016-2021)
3.2 Global Top Recombinant Erythropoietin Drugs Players by Revenue (2016-2021)
3.3 Global Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Erythropoietin Drugs as of 2020)
3.4 Global Recombinant Erythropoietin Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Recombinant Erythropoietin Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Erythropoietin Drugs Market Size by Type
4.1 Global Recombinant Erythropoietin Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Recombinant Erythropoietin Drugs Price by Type (2016-2021)
4.2 Global Recombinant Erythropoietin Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Recombinant Erythropoietin Drugs Price Forecast by Type (2022-2027)
5 Global Recombinant Erythropoietin Drugs Market Size by Application
5.1 Global Recombinant Erythropoietin Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Recombinant Erythropoietin Drugs Price by Application (2016-2021)
5.2 Global Recombinant Erythropoietin Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Recombinant Erythropoietin Drugs Price Forecast by Application (2022-2027)
6 North America Recombinant Erythropoietin Drugs Market Facts & Figures
6.1 North America Recombinant Erythropoietin Drugs Sales by Company
6.1.1 North America Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
6.1.2 North America Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
6.2 North America Recombinant Erythropoietin Drugs Sales Breakdown by Type
6.2.1 North America Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Recombinant Erythropoietin Drugs Sales Breakdown by Application
6.3.1 North America Recombinant Erythropoietin Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Recombinant Erythropoietin Drugs Sales Breakdown by Application (2022-2027)
7 Europe Recombinant Erythropoietin Drugs Market Facts & Figures
7.1 Europe Recombinant Erythropoietin Drugs Sales by Company
7.1.1 Europe Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
7.1.2 Europe Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
7.2 Europe Recombinant Erythropoietin Drugs Sales Breakdown by Type
7.2.1 Europe Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Recombinant Erythropoietin Drugs Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Recombinant Erythropoietin Drugs Market Facts & Figures
8.1 China Recombinant Erythropoietin Drugs Sales by Company
8.1.1 China Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
8.1.2 China Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
8.2 China Recombinant Erythropoietin Drugs Sales Breakdown by Type
8.2.1 China Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
8.3 China Recombinant Erythropoietin Drugs Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Recombinant Erythropoietin Drugs Market Facts & Figures
9.1 Japan Recombinant Erythropoietin Drugs Sales by Company
9.1.1 Japan Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
9.1.2 Japan Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
9.2 Japan Recombinant Erythropoietin Drugs Sales Breakdown by Type
9.2.1 Japan Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Recombinant Erythropoietin Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Recombinant Erythropoietin Drugs Market Facts & Figures
10.1 Southeast Asia Recombinant Erythropoietin Drugs Sales by Company
10.1.1 Southeast Asia Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Recombinant Erythropoietin Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Recombinant Erythropoietin Drugs Sales Breakdown by Application
10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)
11 India Recombinant Erythropoietin Drugs Market Facts & Figures
11.1 India Recombinant Erythropoietin Drugs Sales by Company
11.1.1 India Recombinant Erythropoietin Drugs Sales by Company (2016-2021)
11.1.2 India Recombinant Erythropoietin Drugs Revenue by Company (2016-2021)
11.2 India Recombinant Erythropoietin Drugs Sales Breakdown by Type
11.2.1 India Recombinant Erythropoietin Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Recombinant Erythropoietin Drugs Sales Breakdown by Type (2022-2027)
11.3 India Recombinant Erythropoietin Drugs Sales Breakdown by Application
11.3.1 India Recombinant Erythropoietin Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Recombinant Erythropoietin Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Recombinant Erythropoietin Drugs Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Recombinant Erythropoietin Drugs Products Offered
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Kyowa Hakko Kirin
12.3.1 Kyowa Hakko Kirin Corporation Information
12.3.2 Kyowa Hakko Kirin Business Overview
12.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Products Offered
12.3.5 Kyowa Hakko Kirin Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Business Overview
12.4.3 Roche Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Roche Recombinant Erythropoietin Drugs Products Offered
12.4.5 Roche Recent Development
12.5 3SBio Group
12.5.1 3SBio Group Corporation Information
12.5.2 3SBio Group Business Overview
12.5.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 3SBio Group Recombinant Erythropoietin Drugs Products Offered
12.5.5 3SBio Group Recent Development
12.6 Celltrion, Inc
12.6.1 Celltrion, Inc Corporation Information
12.6.2 Celltrion, Inc Business Overview
12.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Products Offered
12.6.5 Celltrion, Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 F. Hoffmann-La Roche Ltd
12.8.1 F. Hoffmann-La Roche Ltd Corporation Information
12.8.2 F. Hoffmann-La Roche Ltd Business Overview
12.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Products Offered
12.8.5 F. Hoffmann-La Roche Ltd Recent Development
12.9 LG Life Sciences Ltd
12.9.1 LG Life Sciences Ltd Corporation Information
12.9.2 LG Life Sciences Ltd Business Overview
12.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Products Offered
12.9.5 LG Life Sciences Ltd Recent Development
12.10 Biocon Limited
12.10.1 Biocon Limited Corporation Information
12.10.2 Biocon Limited Business Overview
12.10.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Biocon Limited Recombinant Erythropoietin Drugs Products Offered
12.10.5 Biocon Limited Recent Development
12.11 Intas Pharmaceuticals Ltd
12.11.1 Intas Pharmaceuticals Ltd Corporation Information
12.11.2 Intas Pharmaceuticals Ltd Business Overview
12.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Products Offered
12.11.5 Intas Pharmaceuticals Ltd Recent Development
12.12 Sun Pharmaceutical Industries Ltd
12.12.1 Sun Pharmaceutical Industries Ltd Corporation Information
12.12.2 Sun Pharmaceutical Industries Ltd Business Overview
12.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Products Offered
12.12.5 Sun Pharmaceutical Industries Ltd Recent Development
12.13 Dr. Reddy's Laboratories Ltd
12.13.1 Dr. Reddy's Laboratories Ltd Corporation Information
12.13.2 Dr. Reddy's Laboratories Ltd Business Overview
12.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Products Offered
12.13.5 Dr. Reddy's Laboratories Ltd Recent Development
13 Recombinant Erythropoietin Drugs Manufacturing Cost Analysis
13.1 Recombinant Erythropoietin Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Erythropoietin Drugs
13.4 Recombinant Erythropoietin Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Erythropoietin Drugs Distributors List
14.3 Recombinant Erythropoietin Drugs Customers
15 Market Dynamics
15.1 Recombinant Erythropoietin Drugs Market Trends
15.2 Recombinant Erythropoietin Drugs Drivers
15.3 Recombinant Erythropoietin Drugs Market Challenges
15.4 Recombinant Erythropoietin Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Recombinant Erythropoietin Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Recombinant Erythropoietin Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Recombinant Erythropoietin Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Recombinant Erythropoietin Drugs Sales (KG) by Region (2016-2021)
Table 5. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Recombinant Erythropoietin Drugs Revenue Share by Region (2016-2021)
Table 8. Global Recombinant Erythropoietin Drugs Sales (KG) Forecast by Region (2022-2027)
Table 9. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Recombinant Erythropoietin Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Recombinant Erythropoietin Drugs Sales (KG) of Key Companies (2016-2021)
Table 13. Global Recombinant Erythropoietin Drugs Sales Share by Company (2016-2021)
Table 14. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Recombinant Erythropoietin Drugs Revenue Share by Company (2016-2021)
Table 16. Global Recombinant Erythropoietin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Erythropoietin Drugs as of 2020)
Table 17. Global Recombinant Erythropoietin Drugs Average Price (USD/g) of Key Company (2016-2021)
Table 18. Manufacturers Recombinant Erythropoietin Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Erythropoietin Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Recombinant Erythropoietin Drugs Sales (KG) by Type (2016-2021)
Table 22. Global Recombinant Erythropoietin Drugs Sales Share by Type (2016-2021)
Table 23. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Recombinant Erythropoietin Drugs Price (USD/g) by Type (2016-2021)
Table 25. Global Recombinant Erythropoietin Drugs Sales Share by Type (2022-2027)
Table 26. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Recombinant Erythropoietin Drugs Revenue Share by Type (2022-2027)
Table 28. Global Recombinant Erythropoietin Drugs Price (USD/g) by Type (2022-2027)
Table 29. Global Recombinant Erythropoietin Drugs Sales (KG) by Application (2016-2021)
Table 30. Global Recombinant Erythropoietin Drugs Sales Share by Application (2016-2021)
Table 31. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Recombinant Erythropoietin Drugs Price (USD/g) by Application (2016-2021)
Table 33. Global Recombinant Erythropoietin Drugs Sales (KG) by Application (2022-2027)
Table 34. Global Recombinant Erythropoietin Drugs Sales Share by Application (2022-2027)
Table 35. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Recombinant Erythropoietin Drugs Revenue Share by Application (2022-2027)
Table 37. Global Recombinant Erythropoietin Drugs Price (USD/g) by Application (2022-2027)
Table 38. North America Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 39. North America Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 43. North America Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 45. North America Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 47. North America Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 49. North America Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 51. Europe Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 55. Europe Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 57. Europe Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 59. Europe Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 61. Europe Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 62. China Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 63. China Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 64. China Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 67. China Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 68. China Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 69. China Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 70. China Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 71. China Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 72. China Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 73. China Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 75. Japan Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 79. Japan Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 81. Japan Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 83. Japan Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 85. Japan Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 87. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 91. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 93. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 95. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 97. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 98. India Recombinant Erythropoietin Drugs Sales (KG) by Company (2016-2021)
Table 99. India Recombinant Erythropoietin Drugs Sales Market Share by Company (2016-2021)
Table 100. India Recombinant Erythropoietin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Recombinant Erythropoietin Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Recombinant Erythropoietin Drugs Sales by Type (2016-2021) & (KG)
Table 103. India Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021)
Table 104. India Recombinant Erythropoietin Drugs Sales by Type (2022-2027) & (KG)
Table 105. India Recombinant Erythropoietin Drugs Sales Market Share by Type (2022-2027)
Table 106. India Recombinant Erythropoietin Drugs Sales by Application (2016-2021) & (KG)
Table 107. India Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021)
Table 108. India Recombinant Erythropoietin Drugs Sales by Application (2022-2027) & (KG)
Table 109. India Recombinant Erythropoietin Drugs Sales Market Share by Application (2022-2027)
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 113. Amgen Recombinant Erythropoietin Drugs Product
Table 114. Amgen Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Recombinant Erythropoietin Drugs Product
Table 119. Johnson & Johnson Recent Development
Table 120. Kyowa Hakko Kirin Corporation Information
Table 121. Kyowa Hakko Kirin Description and Business Overview
Table 122. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 123. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product
Table 124. Kyowa Hakko Kirin Recent Development
Table 125. Roche Corporation Information
Table 126. Roche Description and Business Overview
Table 127. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 128. Roche Recombinant Erythropoietin Drugs Product
Table 129. Roche Recent Development
Table 130. 3SBio Group Corporation Information
Table 131. 3SBio Group Description and Business Overview
Table 132. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 133. 3SBio Group Recombinant Erythropoietin Drugs Product
Table 134. 3SBio Group Recent Development
Table 135. Celltrion, Inc Corporation Information
Table 136. Celltrion, Inc Description and Business Overview
Table 137. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 138. Celltrion, Inc Recombinant Erythropoietin Drugs Product
Table 139. Celltrion, Inc Recent Development
Table 140. Teva Pharmaceutical Industries Ltd Corporation Information
Table 141. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 143. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product
Table 144. Teva Pharmaceutical Industries Ltd Recent Development
Table 145. F. Hoffmann-La Roche Ltd Corporation Information
Table 146. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 147. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 148. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product
Table 149. F. Hoffmann-La Roche Ltd Recent Development
Table 150. LG Life Sciences Ltd Corporation Information
Table 151. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 152. LG Life Sciences Ltd Description and Business Overview
Table 153. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product
Table 154. LG Life Sciences Ltd Recent Development
Table 155. Biocon Limited Corporation Information
Table 156. Biocon Limited Description and Business Overview
Table 157. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 158. Biocon Limited Recombinant Erythropoietin Drugs Product
Table 159. Biocon Limited Recent Development
Table 160. Intas Pharmaceuticals Ltd Corporation Information
Table 161. Intas Pharmaceuticals Ltd Description and Business Overview
Table 162. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 163. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product
Table 164. Intas Pharmaceuticals Ltd Recent Development
Table 165. Sun Pharmaceutical Industries Ltd Corporation Information
Table 166. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 167. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 168. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product
Table 169. Sun Pharmaceutical Industries Ltd Recent Development
Table 170. Dr. Reddy's Laboratories Ltd Corporation Information
Table 171. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 172. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 173. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product
Table 174. Dr. Reddy's Laboratories Ltd Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Recombinant Erythropoietin Drugs Distributors List
Table 178. Recombinant Erythropoietin Drugs Customers List
Table 179. Recombinant Erythropoietin Drugs Market Trends
Table 180. Recombinant Erythropoietin Drugs Market Drivers
Table 181. Recombinant Erythropoietin Drugs Market Challenges
Table 182. Recombinant Erythropoietin Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Erythropoietin Drugs Product Picture
Figure 2. Global Recombinant Erythropoietin Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Erythropoietin Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Chronic Kidney Disease Examples
Figure 7. Cancer Related Anemia Examples
Figure 8. Others Examples
Figure 9. Global Recombinant Erythropoietin Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Recombinant Erythropoietin Drugs Sales (KG) Growth Rate (2016-2027)
Figure 12. Global Recombinant Erythropoietin Drugs Price Trends Growth Rate (2016-2027) (USD/g)
Figure 13. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Recombinant Erythropoietin Drugs Sales (KG) Growth Rate (2016-2027)
Figure 17. Europe Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Recombinant Erythropoietin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Recombinant Erythropoietin Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Recombinant Erythropoietin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Recombinant Erythropoietin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Recombinant Erythropoietin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Recombinant Erythropoietin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Recombinant Erythropoietin Drugs Players Market Share by Revenue in Recombinant Erythropoietin Drugs: 2016 & 2020
Figure 28. Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Recombinant Erythropoietin Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Recombinant Erythropoietin Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Recombinant Erythropoietin Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Recombinant Erythropoietin Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 34. North America Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 35. Europe Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 36. Europe Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 37. China Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 38. China Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 39. Japan Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 40. Japan Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 43. India Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 44. India Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Recombinant Erythropoietin Drugs
Figure 47. Manufacturing Process Analysis of Recombinant Erythropoietin Drugs
Figure 48. Recombinant Erythropoietin Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Johnson & Johnson Kyowa Hakko Kirin Roche 3SBio Group Celltrion, Inc Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche Ltd LG Life Sciences Ltd Biocon Limited Intas Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Ltd